PIVKA-II as a potential new biomarker for hepatocellular carcinoma–a pilot study
S Svobodova, M Karlikova, O Topolcan, L Pecen… - in vivo, 2018 - iv.iiarjournals.org
Aim: The aim of this study was to evaluate the clinical contribution of protein induced by
vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) diagnostics and compare it …
vitamin K absence (PIVKA-II) for hepatocellular carcinoma (HCC) diagnostics and compare it …
Evaluation of IL-2, IL-6, IL-8 and IL-10 in malignant melanoma diagnostics
…, J Windrichova, R Fuchsova, S Svobodova… - Anticancer …, 2015 - ar.iiarjournals.org
Aim: The aim of the present study was to evaluate the usefulness of four interleukins (IL-2, IL-6,
IL-8 and IL-10) for melanoma detection and correlate these interleukins with sentinel …
IL-8 and IL-10) for melanoma detection and correlate these interleukins with sentinel …
Phylogeny, life history evolution and biogeography of the Rhinanthoid Orobanchaceae
Rhinanthoid Orobanchaceae form a monophyletic lineage that include the hemiparasitic
genera Euphrasia, Melampyrum, Tozzia, Bartsia, Nothobartsia, Odontites (sl), Rhinanthus, …
genera Euphrasia, Melampyrum, Tozzia, Bartsia, Nothobartsia, Odontites (sl), Rhinanthus, …
Evaluation of IGF1 serum levels in malignant melanoma and healthy subjects
…, I Treskova, J Vrzalova, S Svobodova… - Anticancer …, 2014 - ar.iiarjournals.org
Background/Aim: There were two aims in the present study. The first was to evaluate the
usefulness of insulin-like growth factor 1 (IGF1) for melanoma detection. The second was to …
usefulness of insulin-like growth factor 1 (IGF1) for melanoma detection. The second was to …
Reference values of IGF1, IGFBP3 and IGF1/IGFBP3 ratio in adult population in the Czech Republic
…, O Topolcan, L Pecen, J Kinkorova, S Svobodova… - Clinica chimica acta, 2015 - Elsevier
Background IGF1 is responsible for regulation of growth, metabolism and differentiation of
human cells. IGFBP3 is the most abundant of the carrier proteins for IGF1 in the blood. IGF1/…
human cells. IGFBP3 is the most abundant of the carrier proteins for IGF1 in the blood. IGF1/…
Parameters of biological activity in colorectal cancer
S Svobodova, O Topolcan, L HOLUBEC… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The aim of this study was to measure several parameters in patients with early-stage
colorectal cancer (CRC) and to evaluate them for their utility in routine clinical practice…
colorectal cancer (CRC) and to evaluate them for their utility in routine clinical practice…
CEA, CA 15-3, and TPS as prognostic factors in the follow-up monitoring of patients after radical surgery for breast cancer
S Svobodova, R Kucera, O Fiala, M Karlikova… - Anticancer …, 2018 - ar.iiarjournals.org
Aim: The aim of this study was to evaluate the ability of tissue polypeptide-specific antigen (TPS),
carcinoembryonic antigen (CEA), and cancer antigen 15-3 (CA 15-3) to predict relapse …
carcinoembryonic antigen (CEA), and cancer antigen 15-3 (CA 15-3) to predict relapse …
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study
P Pazdiora, S Svobodova, R Fuchsova… - Anticancer …, 2011 - ar.iiarjournals.org
Background: Many studies have demonstrated the relationship between vitamin D and
cancer of many different sites, including of the breast, colorectum, prostate and lung. Most …
cancer of many different sites, including of the breast, colorectum, prostate and lung. Most …
Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers
…, M Cerna, A Narsanska, S Svobodova… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The first aim of this project was to study new possibilities for distinguishing
benign from malignant tumors using growth factors and to compare them with the traditional …
benign from malignant tumors using growth factors and to compare them with the traditional …
CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management
…, J Vrzalova, L Betincova, S Svobodova - Anticancer …, 2014 - ar.iiarjournals.org
Aim: The aim of the present study was to compare the use of cancer antigen 125 (CA125)
and human epididymis protein 4 (HE4) biomarkers in patients with endometrial cancer for …
and human epididymis protein 4 (HE4) biomarkers in patients with endometrial cancer for …